Finder makes money from featured partners, but editorial opinions are our own. Advertiser disclosure

How to buy 10X Genomics stock (TXG)

Buy 10X Genomics stock in 5 easy steps, view past price performance and learn what’s ahead for the company.

10X Genomics is a health information services business based in the US. 10X Genomics shares (TXG) are listed on the NASDAQ and all prices are listed in US Dollars. 10X Genomics employs 1,259 staff and has a trailing 12-month revenue of around $625.4 million.

Our top picks for where to buy 10X Genomics stock

Top pick for advanced traders

Go to site
Get up to $5,000 cash
  • Trade options, futures, options on futures, stocks, ETFs
  • $0 commission to close options
  • Pro-grade platform and risk analysis tools

Our pick for transfer bonus

Go to site
Get up to $10,000 cash
  • Trade stocks, options, ETFs, mutual funds, alternative asset funds
  • $0 commission on stocks, ETFs and options, with no options contract fees
  • No-cost financial planning and automated investing

Our pick for Investing by theme

Go to site
Earn up to $300 on new deposits
  • Trade $0 commission stocks & ETFs with as little as $1
  • Theme and ETF screener
  • Discover new opportunities with Opto's AI-driven classification system

How to buy 10X Genomics stock

  1. Choose a stock trading platform. Use our comparison table
  2. Open an account. Provide your personal information and sign up.
  3. Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
  4. Search for the stock name – TXG. Search for the stock by name or ticker symbol.
  5. Buy the stock. Place your order. It's that simple.

Buy 10X Genomics stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.
1 - 6 of 6
Name Product Ratings Available asset types Stock trade fee Minimum deposit Cash sweep APY Signup bonus
Tastytrade
Finder Score: 4.4 / 5: ★★★★★
Tastytrade
★★★★★
Stocks, Options, ETFs, Cryptocurrency, Futures, Treasury Bills
$0
$0
N/A
Get $50-$5,000
Competitive, capped options commissions, with a reliable trading platform designed for serious traders.
SoFi Invest®
Finder Score: 4.2 / 5: ★★★★★
SoFi Invest®
★★★★★
Stocks, Options, Mutual funds, ETFs, Alternatives
$0
$0
0.02%
Get up to $10,000 cash
Commission-free stocks, ETFs and options, with no options per-contract fees. Plus, a no-cost robo-advisor and complimentary access to certified financial planners (CFPs).
OPTO
Finder Score: 3.1 / 5: ★★★★★
OPTO
★★★★★
Stocks, ETFs
$0
$0
N/A
Earn up to $300
AI-driven thematic investing, with proprietary research, fractional shares and commission-free stocks and ETFs.
Cash App
Finder Score: 3 / 5: ★★★★★
Cash App
★★★★★
Stocks, ETFs, Cryptocurrency
$0
$0
4.5%
N/A
Buy and sell over 1,800 stocks and ETFs commission-free and for as little as $1.
Moomoo
Finder Score: 4.3 / 5: ★★★★★
Exclusive
Moomoo
★★★★★
Stocks, Options, ETFs
$0
$0
Up to 8.10%
Get up to 15 free stocks
No commission stock, ETF and options trades, with $0 equity options contract fees, low margin rates and advanced trading tools.
Public.com
Finder Score: 4.2 / 5: ★★★★★
Public.com
★★★★★
Stocks, Bonds, Options, ETFs, Cryptocurrency, Alternatives, Treasury Bills, High-yield cash account
$0
$0
5.1%
Get up to $10,000 and transfer fees covered
Build a diversified portfolio of stocks, bonds, options, ETFs, crypto and alternative assets, with a high-yield cash account and options contract rebates.
loading

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

10X Genomics stock price (NASDAQ: TXG)

Use our graph to track the performance of TXG stocks over time.

10X Genomics shares at a glance

Information last updated 2024-07-15.
Latest market close$16.70
52-week range$15.28 - $63.57
50-day moving average $22.10
200-day moving average $36.99
Wall St. target price$35.46
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $-2.24

Is it a good time to buy 10X Genomics stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

10X Genomics price performance over time

Historical closes compared with the close of $16.7 from 2024-07-19

1 week (2024-07-15) -3.58%
1 month (2024-06-21) -14.97%
3 months (2024-04-22) -39.93%
6 months (2024-01-22) -61.31%
1 year (2023-07-21) -72.15%
2 years (2022-07-22) -52.44%
3 years (2021-07-22) 185.89
5 years (2019-07-18) N/A

10X Genomics financials

Revenue TTM $625.4 million
Gross profit TTM $396 million
Return on assets TTM -13.06%
Return on equity TTM -34.75%
Profit margin -42.26%
Book value $6.01
Market Capitalization $2.1 billion

TTM: trailing 12 months

10X Genomics share dividends

We're not expecting 10X Genomics to pay a dividend over the next 12 months.

Have 10X Genomics's shares ever split?

10X Genomics's shares were split on a 1:2 basis on 16 July 2006. So if you had owned 2 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your 10X Genomics shares – just the quantity. However, indirectly, the new 100% higher share price could have impacted the market appetite for 10X Genomics shares which in turn could have impacted 10X Genomics's share price.

10X Genomics share price volatility

Over the last 12 months, 10X Genomics's shares have ranged in value from as little as $15.28 up to $63.57. A popular way to gauge a stock's volatility is its "beta".

TXG.US volatility(beta: 1.84)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while 10X Genomics's is 1.841. This would suggest that 10X Genomics's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

10X Genomics overview

10x Genomics, Inc. , a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in the America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium, chromium connect, and chromium controller instruments, microfluidic chips, slides, reagents, and other consumables products. Its single cell solutions runs on its chromium instruments, which include single cell gene expression for measuring gene activity and networks on a cell-by-cell basis; single cell gene expression flex; single cell immune profiling used to study the immune system; single cell Assay for Transposase Accessible Chromati (ATAC) solution to understand the epigenetic state; and single cell multiome ATAC + gene expression which enables simultaneous interrogation of both the RNA and chromatin accessibility, using ATAC in a single cell. The company also provides Visium platform which enables researchers to understand the spatial positions of biological analytes within tissues at high resolution; and Xenium platform for in situ analysis. It serves various academic, government, biopharmaceutical, biotechnology, and other institutions. The company was formerly known as 10X Technologies, Inc.

Frequently asked questions

What percentage of 10X Genomics is owned by insiders or institutions?
Currently 2.167% of 10X Genomics shares are held by insiders and 91.991% by institutions.
How many people work for 10X Genomics?
Latest data suggests 1,259 work at 10X Genomics.
When does the fiscal year end for 10X Genomics?
10X Genomics's fiscal year ends in December.
Where is 10X Genomics based?
10X Genomics's address is: 6230 Stoneridge Mall Road, Pleasanton, CA, United States, 94588-3260
What is 10X Genomics's ISIN number?
10X Genomics's international securities identification number is: US88025U1097
What is 10X Genomics's CUSIP number?
10X Genomics's Committee on Uniform Securities Identification Procedures number is: 88025U109

More guides on Finder

Ask a question

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Go to site